UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Essential medicines for children

Archives of disease in childhood, 2015-02, Vol.100 (Suppl 1), p.S38-S42

2015

Volltextzugriff (PDF)

Why are certain age bands used for children in paediatric studies of medicines?

Archives of disease in childhood, 2021-07, Vol.106 (7), p.631-635

2021

Volltextzugriff (PDF)

Evaluation of Antimicrobial Therapy of Blood Culture Positive Healthcare-Associated Infections in Children

PloS one, 2015-11, Vol.10 (11), p.e0141555

2015

Volltextzugriff (PDF)

Data monitoring committees should be used more frequently and appropriately to monitor paediatric clinical trials, particularly those involving neonates

Acta Paediatrica, 2017-01, Vol.106 (1), p.7-8

Hoppu, Kalle

2017

Volltextzugriff (PDF)

Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms

Pharmacogenetics and genomics, 2008-02, Vol.18 (2), p.77-90

2008

Volltextzugriff (PDF)

Paediatric clinical pharmacology—at the beginning of a new era

European journal of clinical pharmacology, 2008-02, Vol.64 (2), p.201-205

Hoppu, Kalle

2008

Volltextzugriff (PDF)

Reflection: medicines for children—science alone is not enough

European journal of clinical pharmacology, 2013-05, Vol.69 (Suppl 1), p.59-63

Hoppu, Kalle

2013

Volltextzugriff (PDF)

First-order alcohol elimination in severe alcohol intoxication in an adolescent: a case report

The American journal of emergency medicine, 2009, Vol.27 (1), p.128.e5-128.e6

2009

Volltextzugriff (PDF)

Can we get the necessary clinical trials in children and avoid the unnecessary ones?

European journal of clinical pharmacology, 2009-08, Vol.65 (8), p.747-748

Hoppu, Kalle

2009

Volltextzugriff (PDF)

Essential medicines for children

Archives of disease in childhood, 2015-02, Vol.100 (2), p.S38

2015

Volltextzugriff (PDF)

Comparing Pharmacokinetics of Amoxicillin Given Twice or Three Times per Day to Children Older than 3 Months with Pneumonia

Antimicrobial Agents and Chemotherapy, 2003-03, Vol.47 (3), p.997-1001

2003

Volltextzugriff (PDF)

Position paper update: Whole bowel irrigation for gastrointestinal decontamination of overdose patients

Clinical toxicology (Philadelphia, Pa.), 2015-01, Vol.53 (1), p.5-12

2015

Volltextzugriff (PDF)

The selection and use of essential medicines

World Health Organization technical report series, 2009 (958), p.1

WHO Expert Committee

2009

Volltextzugriff (PDF)

Off-label use of antimicrobials in neonates in a tertiary children’s hospital

European journal of clinical pharmacology, 2017-05, Vol.73 (5), p.609-614

2017

Volltextzugriff (PDF)

A clinician’s view of the ethics of the use of biosimilars

GaBI Journal, 2012-09, Vol.1 (3-4), p.112-112

Hoppu, Kalle

2012

Volltextzugriff (PDF)

Increased acetaminophen related calls to Finnish PIC better reflect acetaminophen sales than serious poisonings

Clinical toxicology (Philadelphia, Pa.), 2018-03, Vol.56 (3), p.209-215

2018

Volltextzugriff (PDF)

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project

PloS one, 2015-06, Vol.10 (6), p.e0130399-e0130399

2015

Volltextzugriff (PDF)

Pharmacokinetic Interactions Between Lamotrigine and Other Antiepileptic Drugs in Children with Intractable Epilepsy

Epilepsia (Copenhagen), 1996-08, Vol.37 (8), p.769-773

1996

Volltextzugriff (PDF)

The status of paediatric medicines initiatives around the world—what has happened and what has not?

European journal of clinical pharmacology, 2012, Vol.68 (1), p.1-10

2012

Volltextzugriff (PDF)

How to optimise drug study design: pharmacokinetics and pharmacodynamics studies introduced to paediatricians

Journal of pharmacy and pharmacology, 2017-04, Vol.69 (4), p.439-447

2017

Volltextzugriff (PDF)

Limited impact of EU Paediatric Regulation on Finnish clinical trials highlights need for Nordic collaboration

Acta Paediatrica, 2013-11, Vol.102 (11), p.1035-1040

2013

Volltextzugriff (PDF)

Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial

Neurology, 2004-03, Vol.62 (6), p.883-887

2004

Volltextzugriff (PDF)

Prehepatic metabolism of drugs : a mechanism for low and variable oral bioavailability

Pediatric nephrology (Berlin, West), 1999-01, Vol.13 (1), p.85-89

HOPPU, K

1999

Volltextzugriff (PDF)

Antimicrobial consumption in a tertiary children’s hospital in Finland (2003–2013)

European journal of hospital pharmacy. Science and practice, 2016-09, Vol.23 (5), p.266-271

2016

Volltextzugriff (PDF)

Medication errors made by health care professionals. Analysis of the Finnish Poison Information Centre data between 2000 and 2007

European journal of clinical pharmacology, 2008-08, Vol.64 (8), p.769-774

2008

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(74)
Finnisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Essential medicines for children

Why are certain age bands used for children in paediatric studies of medicines?

Evaluation of Antimicrobial Therapy of Blood Culture Positive Healthcare-Associated Infections in Children

Data monitoring committees should be used more frequently and appropriately to monitor paediatric clinical trials, particularly those involving neonates

Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms

Paediatric clinical pharmacology—at the beginning of a new era

Reflection: medicines for children—science alone is not enough

First-order alcohol elimination in severe alcohol intoxication in an adolescent: a case report

Can we get the necessary clinical trials in children and avoid the unnecessary ones?

Essential medicines for children

Comparing Pharmacokinetics of Amoxicillin Given Twice or Three Times per Day to Children Older than 3 Months with Pneumonia

Position paper update: Whole bowel irrigation for gastrointestinal decontamination of overdose patients

The selection and use of essential medicines

Off-label use of antimicrobials in neonates in a tertiary children’s hospital

A clinician’s view of the ethics of the use of biosimilars

Increased acetaminophen related calls to Finnish PIC better reflect acetaminophen sales than serious poisonings

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project

Pharmacokinetic Interactions Between Lamotrigine and Other Antiepileptic Drugs in Children with Intractable Epilepsy

The status of paediatric medicines initiatives around the world—what has happened and what has not?

How to optimise drug study design: pharmacokinetics and pharmacodynamics studies introduced to paediatricians

Limited impact of EU Paediatric Regulation on Finnish clinical trials highlights need for Nordic collaboration

Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial

Prehepatic metabolism of drugs : a mechanism for low and variable oral bioavailability

Antimicrobial consumption in a tertiary children’s hospital in Finland (2003–2013)

Medication errors made by health care professionals. Analysis of the Finnish Poison Information Centre data between 2000 and 2007

Suchergebnisse filtern